Correlation Between Century Therapeutics and Bluebird Bio
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and Bluebird Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and Bluebird Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and Bluebird bio, you can compare the effects of market volatilities on Century Therapeutics and Bluebird Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of Bluebird Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and Bluebird Bio.
Diversification Opportunities for Century Therapeutics and Bluebird Bio
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Century and Bluebird is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and Bluebird bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bluebird bio and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with Bluebird Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bluebird bio has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and Bluebird Bio go up and down completely randomly.
Pair Corralation between Century Therapeutics and Bluebird Bio
Given the investment horizon of 90 days Century Therapeutics is expected to generate 1.02 times more return on investment than Bluebird Bio. However, Century Therapeutics is 1.02 times more volatile than Bluebird bio. It trades about 0.2 of its potential returns per unit of risk. Bluebird bio is currently generating about -0.15 per unit of risk. If you would invest 128.00 in Century Therapeutics on August 31, 2024 and sell it today you would earn a total of 35.00 from holding Century Therapeutics or generate 27.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Century Therapeutics vs. Bluebird bio
Performance |
| Timeline |
| Century Therapeutics |
| Bluebird bio |
Century Therapeutics and Bluebird Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Century Therapeutics and Bluebird Bio
The main advantage of trading using opposite Century Therapeutics and Bluebird Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, Bluebird Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bluebird Bio will offset losses from the drop in Bluebird Bio's long position.| Century Therapeutics vs. Edgewise Therapeutics | Century Therapeutics vs. C4 Therapeutics | Century Therapeutics vs. Mineralys Therapeutics, Common | Century Therapeutics vs. Cullinan Oncology LLC |
| Bluebird Bio vs. Mersana Therapeutics | Bluebird Bio vs. Zentalis Pharmaceuticals Llc | Bluebird Bio vs. Y mAbs Therapeutics | Bluebird Bio vs. Travere Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |